ArticleJournal of thoracic disease2019

Driving the discussion about the greater propensity for doing better with neoadjuvant chemotherapy for non-small cell lung cancer.

Abigail K Zamora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.